NASDAQ : CRON

Cronos Group Inc.

$2.815 USD

-$0.07 (-2.6%)

Volume
390.95K
Average Volume
1.17M
Market Capitalization
$1.05B
P/E Ratio
-1280.03
Dividend Yield
0.00%
Price Target
$2.90
Year High
$3.43
Year Low
$1.93
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$21.87
Company Overview

NASDAQ

Michael Ryan Gorenstein

Drug Manufacturers - Specialty & Generic

Healthcare

CRON

610

CA

USD

https://www.thecronosgroup.com

14165040004

22717L101

0001656472

Liquidity Metrics

0.00

21.87

20.73

19.37

0.00

Sales & Valuation

$149.15M

6.60

0.99

39.78

0.07

Profitability

-$0.0251

-$9.61M

-1.29%

-4.22%

-0.19%

-0.18%

P/E Metrics

-1280.03

10.18

10.18

Analyst Price Target & Rating

$2.90

$4.50

$2.30

Neutral

3/5

15 Analysts

-2.93%

Financial Health Scores

14.78

3/9

$888.37M

$1.18B

$48.45M

-$15.04M

Key Metrics (TTM)

$261.41M

1.64

5.47

21.87

-0.19%

0.78%

-0.19%

2.44%

272 days

Company Executives
Name Title
Terry Gregory-Joseph Doucet General Counsel & Corporate Secretary
Jeffrey David Jacobson Chief Growth Officer
Adam Wagner General Manager of Cronos Israel
Harrison Aaron Senior Director of Investor Relations & Corporate Development
Anna Shlimak Chief Financial Officer
Shannon Buggy Senior Vice President & Global Head of People
Arye Weigensberg Senior Vice President and Head of Research & Development
Michael Ryan Gorenstein President, Chief Executive Officer & Chairman
Jared Matthew Kenost Principal Accounting Officer, Vice President & Controller
Poll Results

No votes yet today — be the first to share your view!

About Cronos Group Inc. (NASDAQ:CRON) Stock

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed thro ... ugh the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Cyprus: TotalEnergies Approves the Development of the Cronos Gas Field to Supply Europe with LNG

2026-07-28 02:59:00

PARIS--(BUSINESS WIRE)--TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) (50%) and Eni (50%, operator), partners in Cyprus offshore Block 6, have taken the Final Investment Decision (FID) for the development of the Cronos gas field, discovered in 2022 and successfully appraised in 2024. Located in deep offshore waters approximately 185 kilometers southwest of the coast of Cyprus, Cronos will be developed through four subsea wells. The gas will be transported by subsea pipeline from Cypriot waters.

Cronos' SOURZ by Spinach® Expands its Lineup of Edibles

2026-07-21 07:30:00

Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

2026-07-16 07:30:00

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

3 Canadian Marijuana Stocks For Better Investing And Trading 2026

2026-07-15 11:21:32

For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.

Top Canadian Marijuana Stock Picks For Investors Today

2026-07-06 12:42:01

As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.

Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

2026-06-30 17:15:00

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.

CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?

2026-06-24 09:25:32

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

Frequently Asked Questions

What is the current Cronos Group Inc. (CRON) stock price?

Cronos Group Inc.(NASDAQ:CRON) stock price is $2.815 in the last trading session. During the trading session, CRON stock reached the peak price of $3.43 while $1.925 was the lowest point it dropped to. The percentage change in CRON stock occurred in the recent session was --2.6% while the dollar amount for the price change in CRON stock was -$0.07.

CRON's industry and sector of operation?

The NASDAQ listed CRON is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CRON?

Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary
Jeffrey David Jacobson | Chief Growth Officer
Adam Wagner | General Manager of Cronos Israel
Harrison Aaron | Senior Director of Investor Relations & Corporate Development
Anna Shlimak | Chief Financial Officer

How many employees does CRON have?

Number of CRON employees currently stands at 610. CRON operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.

Link for CRON official website?

Official Website of CRON is: https://www.thecronosgroup.com

How do I contact CRON?

CRON could be contacted at phone #14165040004 and can also be accessed through its website. CRON operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.

How many shares of CRON are traded daily?

The average number of CRON shares traded daily for last 3 months was 1.17M.

What is the market cap of CRON currently?

The market value of CRON currently stands at $1.05B with its latest stock price at $2.815